Explore Sections
Innovation and Research
Pitt Collaborates with Pharma Company on Eye Treatments
Debasish Sinha will work with Astellas Pharma Inc. in a new research collaboration to address dry age-related macular degeneration—a common cause of vision loss.
Study: Therapy Leads to Fewer Hospital Readmissions for Pneumonia Patients
New Pitt research published in the Journal of the American Medical Association has found that occupational and physical therapy after hospitalization for pneumonia is associated with a decreased risk of readmission and death in the month following discharge.
Watch: Researchers Take Filmmaking to the Health Sciences
Sara Baumann (GSPH ’19) and Jessica Burke have created a new form of public health research called Collaborative Filmmaking. The six-step process engages its participants to create a detailed, multimedia form of study rarely seen in the field.
Pitt ranked No. 1 for small business support
The University of Pittsburgh Small Business Development Center has been chosen by the U.S. Small Business Administration as the national SBDC Excellence and Innovation Award winner of 2020.
Drug Supply Drop Likely Behind 2018 Overdose Death Downturn
Pitt Public Health scientists found that a drop in the supply of carfentanil, a potent drug, was likely the reason behind 2018's decrease in overdose deaths, rather than U.S. efforts to curb them.
Student Research Could Make Solar Energy More Efficient
Sooraj Sharma (ENGR ’20) and a team of Pitt students created a type of self-cleaning glass that allows more solar energy to reach the power-generating portion of solar panels.
Epidemics and Pandemics Can Exacerbate Xenophobia, Bigotry
In a pair of studies, ecologist Jessica Stephenson found that both animals and humans instinctually hunker down in small groups when infection looms—but that impulse can come with a price.
Pitt Scientists Discover Tiny Antibody Component That is Highly Effective in Preventing and Treating SARS-CoV-2 Infection in Animal Models
The discovery in animals is being used to make a drug for potential therapeutic and preventive use against COVID-19 in humans.
Survey Shows Research-Related Staff and Postdocs Comfortable with Restart Efforts
A recent survey of University research-related staff and postdocs shows that nearly two-thirds of respondents felt that Pitt’s research restart had gone at least as well as or better than they expected.
University of Pittsburgh Selected to Lead NIH Trials in COVID-19 Care
The National Institutes of Health has selected Pitt to lead a trio of Phase 3 clinical trials involving COVID-19 patients that will explore the use of blood thinners in saving lives and improving care.

